Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.84 EUR | 0.00% | +5.14% | 0.00% |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Pangaea Oncology, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Sales 2024 * | 13.8M 14.94M 1.19B | Sales 2025 * | 14.8M 16.02M 1.27B | Capitalization | 54.18M 58.64M 4.66B |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.08M -85.96M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 4.32 x |
Net Debt 2024 * | 5.5M 5.95M 473M | Net Debt 2025 * | 6.8M 7.36M 584M | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
-36.8
x | P/E ratio 2025 * |
-92
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.08% |
1 week | +5.14% | ||
Current month | +5.14% | ||
1 month | -1.08% | ||
3 months | +1.10% | ||
6 months | -1.08% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 | |
Founder | - | 31/12/06 |
Date | Price | Change | Volume |
---|---|---|---|
14/05/24 | 1.84 | 0.00% | 0 |
13/05/24 | 1.84 | 0.00% | 0 |
10/05/24 | 1.84 | +3.95% | 3,349 |
09/05/24 | 1.77 | +1.14% | 400 |
08/05/24 | 1.75 | 0.00% | 5 |
Delayed Quote BME, May 14, 2024 at 03:00 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 58.48M | |
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- PANG Stock